Cargando…
Exploration of Bacterial Re-Growth as In Vitro Phenomenon Affecting Methods for Analysis of the Antimicrobial Activity of Chimeric Bacteriophage Endolysins
Drug alternatives to combat methicillin-resistant Staphylococcus aureus (MRSA) in human and animal healthcare are urgently needed. Recently, the recombinant bacteriophage endolysins, PRF-119 and its successor substance HY-133, have proven to be highly active against various S. aureus clonal lineages...
Autores principales: | Kaspar, Ursula, Schleimer, Nina, Idelevich, Evgeny A., Molinaro, Sonja, Becker, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877451/ https://www.ncbi.nlm.nih.gov/pubmed/35208898 http://dx.doi.org/10.3390/microorganisms10020445 |
Ejemplares similares
-
In Vitro Activity of the Bacteriophage Endolysin HY-133 against Staphylococcus aureus Small-Colony Variants and Their Corresponding Wild Types
por: Schleimer, Nina, et al.
Publicado: (2019) -
Vascular Graft Impregnation with Antibiotics: The Influence of High Concentrations of Rifampin, Vancomycin, Daptomycin, and Bacteriophage Endolysin HY-133 on Viability of Vascular Cells
por: Herten, Monika, et al.
Publicado: (2017) -
Plasmid-Encoded Transferable mecB-Mediated Methicillin Resistance in Staphylococcus aureus
por: Becker, Karsten, et al.
Publicado: (2018) -
Antimicrobial Potential of the Genera Geobacillus and Parageobacillus, as Well as Endolysins Biosynthesized by Their Bacteriophages
por: Zebrowska, Joanna, et al.
Publicado: (2022) -
A bacteriophage endolysin that eliminates intracellular streptococci
por: Shen, Yang, et al.
Publicado: (2016)